Sitryx
PrivateLast Round
Series A
Extension
Sep 27, 2023
Total Funding Raised
$89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sitryx is a biopharmaceutical company that develops disease-modifying therapeutics in immuno-oncology and immuno-inflammation by regulating cell metabolism.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sitryx Comparables
Compare Sitryx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| META Pharmaceuticals Inc. | 82% | |
| Lmito Therapeutics | 79% | |
| Aclaris Therapeutics | 76% | |
Sitryx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 27, 2023 | ||||
| Corporate Funding | Mar 31, 2020 | ||||
| Corporate Funding | Mar 1, 2020 | ||||
| Series A | Oct 8, 2018 |
Key People
Founding team and executive leadership
Sitryx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Seed, Series A Extension, Series A |
| Oxford Science Enterprises | Series A Extension |
| Oxford Science Enterprises | Series A Extension |
| Sofinnova Partners | Series A Extension, Series A |
| Longwood Fund | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Lead glutaminase-1 (GLS1) inhibitor nominated for development.
- Nov 12, 2025
Presented preclinical data at the 6th Inflammatory Skin Disease Summit.
Sitryx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sitryx's valuation, stock price, and market status.